Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

Michael Reardon, MD, Susheel Kodali, MD, and Vinod Thourani, MD discuss the SURTAVI trial and the SAPIEN 3 study in intermediate-risk patients as well as the outcomes of TAVR and SAVR. The safety and complications of the procedure are explored, as well as the potential to improve patient outcomes in light of the evolving indications of TAVR.

We Recommend